Administration of N-carbamylglutamate (NCG), an analogue of endogenous N-acetyl-glutamate (an activator of arginine synthesis) offers been shown to improve neonatal development by increasing circulating arginine amounts. and activator of transcription 3 (Stat3), proteins kinase B (PKB), and 70-kDa ribosomal proteins S6 kinase (S6K1) through the periimplantation period, leading to a rise in litter size however,… Continue reading Administration of N-carbamylglutamate (NCG), an analogue of endogenous N-acetyl-glutamate (an activator